相关实验视频

Updated: May 25, 2025

Author Spotlight: Decoding Mitochondrial Aging

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

线粒体功能障碍与唐氏综合征中的大脑粉样蛋白结合,记忆和执行功能相关:对唐氏综合征中的阿尔茨海默病的影响

Jessica A Beresford-Webb¹, Catherine J McAllister¹, Alison Sleigh²

¹Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Douglas House, Trumpington Road, Cambridge CB2 8AH, UK.

|February 26, 2025

概括

线粒体功能障碍与患有唐氏综合征 (DS) 的成年人的大脑粉样β积累和认知衰退有关,这表明DS相关的阿尔茨海默病 (DSAD) 可能是潜在的治疗点.

科学领域:

神经科学是一个神经科学.
线粒体生物学线粒体生物学
遗传学是一个遗传学.

背景情况:

线粒体功能障碍是神经退行和认知衰退的关键因素.
患有唐氏综合征 (DS) 的人患神经退行症,特别是阿尔茨海默病 (AD) 的风险较高.

研究的目的:

调查线粒体功能障碍,大脑粉样β (Aβ) 沉积和DS成年人的认知衰退之间的关系.
探索针对DS相关AD (DSAD) 的线粒体路径的潜在治疗策略.

主要方法:

试点研究涉及10名患有DS的成人.
在骨肌中通过-31磁共振光谱 (31P-MRS) 评估线粒体功能.
使用11C-匹兹堡化合物B (PiB-PET) 测量大脑Aβ沉积.
使用适应唐氏综合征 (CAMCOG-DS) 患者的剑桥认知检查和执行功能测试来评估认知表现.

主要成果:

缓慢的脂蛋白 (PCr) 恢复与增加的大脑Aβ沉积相关,特别是在条形体.
认知表现,特别是记忆和执行功能,与线粒体功能相反相关.
一个具有APOE-ε4等位基因的个体表现出最严重的线粒体功能障碍,Aβ负担和认知障碍.

结论:

线粒体功能障碍在DS相关的AD (DSAD) 中起着重要作用,并影响DS成年人的认知能力.
准线粒体路径可能提供一种治疗方法,以减轻DS群体的AD进展.
需要对更大的队列和纵向设计进行进一步的研究,以确认致病机制并开发干预措施.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.唐氏综合征是什么意思唐氏综合征痴呆症痴呆症是一种痴呆症.线粒体中的线粒体.

更多相关视频

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Mitochondria

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...